Simulations Plus Non-GAAP EPS of $0.13 misses by $0.07, revenue of $18.42M beats by $0.36M
Source: SeekingAlpha
2026-01-08 16:09:36 ET
More on Simulations Plus
- Simulations Plus: Solid Platform, Soft Outlook (Rating Upgrade)
- Simulations Plus: Buying On Long-Term Silico Drug-Development
- Simulations Plus, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Simulations Plus Q1 2026 Earnings Preview
- Simulations Plus outlines $79M–$82M FY 2026 revenue target as AI and cloud integration strategy advances
Read the full article on Seeking Alpha
For further details see:
Simulations Plus Non-GAAP EPS of $0.13 misses by $0.07, revenue of $18.42M beats by $0.36M
Simulations Plus Inc.
NASDAQ: SLP
SLP Trading
2.93% G/L:
$12.29 Last:
66,161 Volume:
$12.10 Open:
SLP Latest News
March 03, 2026 07:55:00 am
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
February 09, 2026 06:45:00 pm
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
January 21, 2026 04:05:00 pm
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
SLP Stock Data
$281,347,060
16,298,587
16.67%
64
N/A
Healthcare Providers & Services
Healthcare
US
Research Triangle Park
